Incannex Healthcare Ltd (ASX: IHL) has announced a trading halt
Incannex Healthcare Ltd (ASX: IHL) has announced a trading halt.
There are a few reasons why a stock would go into a trading halt. It is generally ahead of a news announcement.
Incannex Healthcare Ltd has requested the trading halt pending an announcement by the Company regarding preliminary results of its phase 2 clinical trial assessing IHL-42X in patients with obstructive sleep apnoea.
Trading halts are typically enacted in anticipation of a news announcement, to correct an order imbalance, as a result of a technical glitch or due to regulatory concerns.
Halts may also be triggered by severe down moves, in what are called circuit breakers or curbs.
The trading halt will remain in place until normal trading commences on March 10, 2022 or when the company announcement is made.
Read the full story
in the Grafa app
To read the full article and more in the Grafa app, available on all app stores.
Track the trends
Get the hot tips first
Stay close to your investments
Learn to trade like a pro
Let your money entertain you
See more stories like this
48% of businesses say they will not raise prices, primarily due to the desire to...read more